SCHEMBL9493769

SCHEMBL9493769

CCOC(=O)CC(c1ccccc1)N1C(=O)c2cc(CCC(=O)NCCNC(=O)OC(C)(C)C)ccc2N(c2ccccc2)C(=O)C1c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2D6 P10635 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31
NCOR2 Q9Y618 1/20 0.31
SIGMAR1 Q99720 2/20 0.31
MALT1 Q9UDY8 1/20 0.31
TPSAB1 Q15661 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492960 0.92 PDCD1 (0.38) PDCD1CD274CYP3A4CYP2C19HDAC3
SCHEMBL9493733 0.92 PDCD1 (0.36) PDCD1CD274CYP3A4CYP2C19CYP2D6
SCHEMBL7324643 0.91 PDCD1 (0.36) PDCD1CD274SIGMAR1TPSAB1TPSD1
SCHEMBL9494267 0.91 PDCD1 (0.36) PDCD1CD274CYP3A4CYP2C19CYP2D6
SCHEMBL9493643 0.90 PDCD1 (0.35) PDCD1CD274CYP3A4CYP2C19CYP2D6
SCHEMBL7327994 0.90 NR1H2 (0.31)
SCHEMBL7322604 0.85 SCN9A (0.32) PDCD1CD274GAA
SCHEMBL9493013 0.84 PDCD1 (0.37) PDCD1CD274CYP3A4CYP2C19HDAC3
SCHEMBL7328669 0.83 PDCD1 (0.37) PDCD1CD274SIGMAR1TPSAB1TPSD1
SCHEMBL7318601 0.83 TPSAB1 (0.36) PDCD1CD274HDAC3HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed